Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Connections

Sophia Malandraki-Miller

D.Phil. / PhD


Postdoctoral Research Scientist

Identifying drugs to stimulate endogenous cardiac progenitor cells for heart regeneration after infarction

Sophia Malandraki-Miller studied Applied Biology & Biotechnology at University of Ioannina, in Greece.

She then completed her PhD studies in Department of Physiology, Anatomy & Genetics - University of Oxford in Prof. C. Carr's group. Her research was conducted on cardiac progenitor cells (isolation methods, metabolism, differentiation, and miRNA pre-conditioning) and stem cell therapy.

In 2017 she started as a Postdoctoral Research Scientist in Prof. Paul Riley’s group at DPAG, jointly working for Oxstem, a University of Oxford spin-out focusing on stem cell drug discovery.

She is currently investigating the activation of adult endogenous epicardial progenitor cells, using small molecules, with the ultimate goal to treat myocardial infarction.

False False